Singapore markets closed
Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
68,420.36 +1,180.95 (+1.76%) CMC Crypto 200
1,383.12 +52.52 (+3.95%)
Atea Pharmaceuticals, Inc. (AVIR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 329.31M |
| Enterprise value | -209.96M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.65 |
| Enterprise value/revenue | 58.97 |
| Enterprise value/EBITDA | -260.47 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.18 |
| 52-week change 3 | 14.29% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 4.6000 |
| 52-week low 3 | 2.7650 |
| 50-day moving average 3 | 3.5998 |
| 200-day moving average 3 | 3.5687 |
Share statistics
| Avg vol (3-month) 3 | 263.19k |
| Avg vol (10-day) 3 | 206.15k |
| Shares outstanding 5 | 84.22M |
| Implied shares outstanding 6 | 84.22M |
| Float 8 | 64.42M |
| % held by insiders 1 | 9.58% |
| % held by institutions 1 | 66.88% |
| Shares short (15 Jul 2024) 4 | 2.37M |
| Short ratio (15 Jul 2024) 4 | 8.36 |
| Short % of float (15 Jul 2024) 4 | 3.96% |
| Short % of shares outstanding (15 Jul 2024) 4 | 2.82% |
| Shares short (prior month 14 Jun 2024) 4 | 2.13M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -15.56% |
| Return on equity (ttm) | -29.16% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -147.83M |
| Net income avi to common (ttm) | -163.66M |
| Diluted EPS (ttm) | -1.9500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 541.49M |
| Total cash per share (mrq) | 6.43 |
| Total debt (mrq) | 2.21M |
| Total debt/equity (mrq) | 0.44% |
| Current ratio (mrq) | 13.28 |
| Book value per share (mrq) | 5.99 |
Cash flow statement
| Operating cash flow (ttm) | -95.41M |
| Levered free cash flow (ttm) | -9.22M |
© 2024 Yahoo. All rights reserved.